Skip to main content
Jennifer (Taylor) Taylor-Cousar, MD, Medicine/Pediatrics, Denver, CO

JenniferL(Taylor)Taylor-CousarMD

Medicine/Pediatrics Denver, CO

Professor, Medicine and Pediatrics, National Jewish Health, University of Colorado School of Medicine

Dr. Taylor-Cousar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Taylor-Cousar's full profile

Already have an account?

  • Office

    1400 Jackson St
    National Jewish Health
    Denver, CO 80206
    Phone+1 303-388-4461
    Fax+1 303-270-2206

Summary

  • Dr. Jennifer Taylor-Cousar is an adult and pediatric pulmonologist in Denver, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, Saint Joseph's Hospital, National Jewish Health, and Children's Hospital Colorado. She received her medical degree from Duke University School of Medicine and has been in practice 19 years. She is experienced in bronchiectasis, cystic fibrosis, and pseudomonas .

Education & Training

  • University of Colorado, Anschutz Medical Campus
    University of Colorado, Anschutz Medical CampusM.S., Clinical Science, 2012 - 2015
  • Duke University Hospital
    Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2006
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine/Pediatrics, 1998 - 2002
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1998
  • Stanford University
    Stanford UniversityB.A., Human Biology, 1993

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2009 - 2025
  • KS State Medical License
    KS State Medical License 2021 - 2025
  • MT State Medical License
    MT State Medical License 2021 - 2025
  • OK State Medical License
    OK State Medical License 2021 - 2025
  • WY State Medical License
    WY State Medical License 2021 - 2025
  • NM State Medical License
    NM State Medical License 2006 - 2024
  • TX State Medical License
    TX State Medical License 2021 - 2024
  • American Board of Internal Medicine Pulmonary Disease
  • American Board of Pediatrics Pediatric Pulmonology
  • Join now to see all

Awards, Honors, & Recognition

  • Elected Member, American Society for Clinical Investigation ASCI, 2020
  • Clinical Quality Award National Jewish Health, 2015
  • Physician of the Year Nominee Saint Joseph Hospital, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Ivacaftor in patients with cystic fibrosis, and a G551D-CFTR mutation: expanded acces program in the United States  
    Taylor-Cousar JL, Nikknian M, Gilmartin G and Pilewski J, J Cyst Fibros, 1/11/2015
  • Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis  
    Rowe SM, Heltshe SL, Gonska T, Donaldson SH, Borowitz D, Gelfond D, Sagel SD, Khan U, Mayer-Hamblett N, Van Dalfsen JM, Joseloff E, Ramsey BW; GOAL Investigators of th..., Am J Respir Crit Care Med, 1/15/2014
  • Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)  
    McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PE..., Lancet Respir Med, 1/1/2014
  • Join now to see all

Abstracts/Posters

  • The Pharmacokinetics of N91115, An Inhibior of S Nitrosoglutathione Reductase in Cystic Fibrosis Patients
    Solomon G, Zemanick E, Taylor-Cousar, JL, Pediatr Pulmonol Suppl, 1/1/2015
  • Use of clofazimine in difficult to treat nontuberculous mycobacterial infections
    Martiniano S, Sagel, S, Zemanick, E, DeVoogd, R, Accurso, F, Nick, J, Saavedra, M, Nichols, D, Taylor-Cousar, J, Levin, A, Czaja, C, Huitt, G, Kasperbauer, S, Daley, C, Pediatr Pulmonol Suppl, 1/1/2014
  • Correlation of a semi-quantitative lung magnetic resonance imaging score with baseline lung function in Cystic Fibrosis
    Taylor-Cousar JL, Jin GY, Nambu A, Bieder J, Newell JD, Chung J, St. Clair C, Jones M, Puderbach M, Nichols DP, Saavedra MT, Schroeder J and Nick JA, NACFC, 1/1/2011
  • Join now to see all

Lectures

  • Adult Issues in Cystic Fibrosis 
    1/1/2016
  • Update in Cystic Fibrosis 
    Phoenix, AZ - 1/1/2016
  • CF Update: CFTR Directed Therapies 
    Keystone, CO - 1/1/2015
  • Join now to see all

Other

Press Mentions

  • A Brand New Era of the Genome, but Persistent Disparities
    A Brand New Era of the Genome, but Persistent DisparitiesJune 4th, 2024
  • ‘They Are the Gatekeepers in Patient Care’: What We Heard This Week
    ‘They Are the Gatekeepers in Patient Care’: What We Heard This WeekApril 9th, 2023
  • Double CF Combination Safe, Effective in 1- to 2-Year-Olds
    Double CF Combination Safe, Effective in 1- to 2-Year-OldsDecember 30th, 2022
  • Join now to see all